Eurofins · 2 days ago
Cell Core Analyst
Rensselaer, NY, USA
Full-time
Onsite
New Grad, Entry Level
$21.50/hr - $22.50/hrEurofins is a global leader in life sciences, providing analytical testing across various industries. The Cell Core Analyst will perform tasks necessary to maintain cell lines for clinical bioassay testing and ensure compliance with standard operating procedures.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
No H1B
Responsibilities
Maintain both suspension and adherent mammalian cell lines
Support any thawing or banking activities for clinical cell lines
Prepare required media for cell lines
Follow and comply with all governing standard operating procedures
Complete laboratory documentation and review logbook data
Calibrate or verify calibration of instruments/devices prior to use
Participate in required training activities
Maintain laboratory supplies
Interact with outside customers or functional peer groups
Qualification
Required
Bachelor's degree in biochemistry or other science related degree concentration
Experience with handling of mammalian cell lines
Experience operating within a GMP environment
Expert in pipetting and pipetting technique
Authorization to work in the United States indefinitely without restriction or sponsorship
Preferred
Is self-motivated, adaptable, team-oriented, and has a positive attitude
Ability to learn new techniques, perform multiple tasks simultaneously, keep accurate records, follow instructions, and comply with company policies
Excellent communication (oral and written) and attention to detail
Desire to work in a moderately physical role that requires standing much of the time
Strong computer and organizational skills
Fosters a healthy, trusting environment and champions transparency and communication
Familiarity with LIMS
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Founded in 1987
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $584.64M
2025-03-27Post Ipo Debt· $432.03M
2021-10-22Grant· $30M
Leadership Team
C
Cara Ahern
Documentation Specialist
Yves-Loic Martin
Board Member
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase